David Szekeres | Executive Vice President, Chief Operating Officer |
Barry Quart | Chairman and Chief Executive Officer |
John Poyhonen | President and Chief Commercial Officer |
Josh Schimmer | Evercore |
Brandon Folkes | Cantor Fitzgerald |
Serge Belanger | Needham and Company |
Good day, ladies and gentlemen. Thank you for standing by. Welcome to the Heron Therapeutics Fourth Quarter 2022 Earnings Conference.
As a reminder, this conference is being recorded.
And now I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer.